Severe recalcitrant psoriasis

Severe recalcitrant psoriasis is an advanced, treatment-resistant clinical state of psoriasis, a chronic immune-mediated inflammatory disorder primarily affecting the skin Pathophysiologically driven by dysregulated T-cell activation and sustained pro-inflammatory cytokine signaling (notably TNF-alpha, IL-23, and IL-17), it manifests clinically as hyperkeratotic, erythematous plaques with thick silvery scales, prominent pruritus, and substantial physical disability

Severe recalcitrant psoriasis is an advanced, treatment-resistant clinical state of psoriasis, a chronic immune-mediated inflammatory disorder primarily affecting the skin

It is characterized by extensive epidermal involvement—frequently covering greater than 10% of body surface area or critically impairing high-impact functional areas—that has failed to respond adequately to standard modalities, including topical agents, phototherapy, and conventional systemic therapies

It is characterized by extensive epidermal involvement—frequently covering greater than 10% of body surface area or critically impairing high-impact functional areas—that has failed to respond adequately to standard modalities, including topical agents, phototherapy, and conventional systemic therapies

It is characterized by extensive epidermal involvement—frequently covering greater than 10% of body surface area or critically impairing high-impact functional areas—that has failed to respond adequately to standard modalities, including topical agents, phototherapy, and conventional systemic therapies Pathophysiologically driven by dysregulated T-cell activation and sustained pro-inflammatory cytokine signaling (notably TNF-alpha, IL-23, and IL-17), it manifests clinically as hyperkeratotic, er...

Pathophysiologically driven by dysregulated T-cell activation and sustained pro-inflammatory cytokine signaling (notably TNF-alpha, IL-23, and IL-17), it manifests clinically as hyperkeratotic, erythematous plaques with thick silvery scales, prominent pruritus, and substantial physical disability

Pathophysiologically driven by dysregulated T-cell activation and sustained pro-inflammatory cytokine signaling (notably TNF-alpha, IL-23, and IL-17), it manifests clinically as hyperkeratotic, erythematous plaques with thick silvery scales, prominent pruritus, and substantial physical disability